Stock listing

gettex:DAP Danaher Corporation Aktie

German listing (gettex) of Danaher Corporation · home listing NYSE:DHR

Follow Danaher Corporation into a list and get an email when it puts out news.

Home listing price · NYSE:DHR

$229.04 USD -2.46 (-1.1%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:DHR

Since Jul 6, 2026 +18.3% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$228.36 – $231.93 USDOct 16, 2026
Volume
3.52M sharesOct 16, 2026
Market value
$161.0B USDAt the close on Oct 16, 2026 · price × 703.0M shares outstanding
Danaher Corporation logo
Ticker
gettex:DAP
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
gettex
Currency
EUR

What changed lately

Calls

Upcoming

  • Danaher (NYSE:DHR) Q3 2026 Earnings Call

    Wed, Oct 21, 2026 · 8:00 AM ET

    Register

Replays

  • Danaher (NYSE:DHR) Q2 2026 Earnings Call

    Tue, Jul 21, 2026 · 8:00 AM ET

    Watch Transcript

  • Danaher (NYSE:DHR) Q1 2026 Earnings Call

    Tue, Apr 21, 2026 · 8:00 AM ET

    Watch Transcript

  • Danaher (NYSE:DHR) Q4 2025 Earnings Call

    Wed, Jan 28, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Beckman Coulter Diagnostics Names Catherine Jennings as President

Oct 14, 2026

Danaher Collaborates with NVIDIA to Advance Autonomous Science

Oct 14, 2026

Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors

Oct 12, 2026

Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale

Oct 8, 2026

Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab

Oct 7, 2026

Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer

Oct 1, 2026

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

Sep 28, 2026

SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics

Sep 28, 2026

Danaher Schedules Third Quarter 2026 Earnings Conference Call

Sep 22, 2026

WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC

Sep 3, 2026

All Danaher Corporation news

Decks

Danaher Corporation on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
56 in the last 12 months · 85 in all · newest Oct 14, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Jul 21, 2026
Decks
40 decks · latest Jul 21, 2026

Where Danaher Corporation is listed

ListingExchangeCountryCurrency
NYSE:DHR · Home listingNYSEUnited StatesUSD
gettex:DAP · This pagegettexGermanyEUR
Tradegate:DAPTradegateGermanyEUR
Xetra:DAPXetraGermanyEUR
BCBA:DHRBCBAArgentinaARS
Frankfurt:DAPFrankfurtGermanyEUR
B3:DHER34B3BrazilBRL
LS Exchange:866197LS ExchangeGermanyEUR
BMV:DHRBMVMexicoMXN
Lang & Schwarz:866197Lang & SchwarzGermanyEUR
Stuttgart:DAPStuttgartGermanyEUR
BCBA:DHRDBCBAArgentinaUSD
Milan:1DHRMilanItalyEUR
BOATS:DHRBOATSUnited StatesUSD
LSE:0R2BLSEUnited KingdomUSD
EUROTLX:4DHREUROTLXItalyEUR
BCBA:DHRCBCBAArgentinaUSD
Munich:DAPMunichGermanyEUR
SIX Swiss:DHRSIX SwissSwitzerlandCHF
BIVA:DHRBIVAMexicoMXN
BX Swiss:DAPBX SwissSwitzerlandCHF
Dusseldorf:DAPDusseldorfGermanyEUR
Hanover:DAPHanoverGermanyEUR
SIX Swiss:DHR.USDSIX SwissSwitzerlandUSD
VIE:DHRCViennaAustriaEUR
Hamburg:DAPHamburgGermanyEUR
Aquis:DAPDAquisUnited KingdomEUR
Aquis:DAPDAquisUnited KingdomEUR
BCBA:DHR.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Danaher Corporation.